LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

Home・Listă Acțiuni・Repligen Corp

Repligen Corp

Deschisă

Sector Sănătate

140.39 0.27

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

138.95

Maxim

141.78

Indicatori cheie
By Trading Economics
Venit	1.2M 3.3M
Vânzări	2.7M 154M
P/E Medie Sector	466.89 103.001
EPS	0.33
Marjă de profit	2.156
Angajați	1,783
EBITDA	3.2M 27M

Recomandări
By TipRanks
Recomandări	Puternic Cumpărare
Prognoză pe 12 luni	+39.45 upside

Dividende
By Dow Jones
Următoarele câștiguri	29 oct. 2024

Statistici piață
By TradingEconomics
Capitalizare de piață	-49M 8.4B
Deschiderea anterioară	140.12
Închiderea anterioară	140.39

Sentimentul știrilor

By Acuity

50%

97 / 365 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bearish Evidence

138.8 / 147.07 Suport & Rezistență

Repligen Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

14 sept. 2024, 01:45 UTC

Câștiguri

Preview -- Barron's

13 sept. 2024, 20:03 UTC

Top știri

Walgreens to Pay $106.8 Million Over Alleged Fraudulent Healthcare Billings

15 sept. 2024, 23:47 UTC

Market Talk

Gold Edges Higher Amid Mild Dollar Weakness -- Market Talk

15 sept. 2024, 23:03 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15 sept. 2024, 23:03 UTC

Market Talk

Australian Bond Traders Watchful as Fed Easing Nears -- Market Talk

15 sept. 2024, 16:52 UTC

Top știri

Boeing Machinist Strike Adds Cash Crunch to New CEO's Rescue Mission -- WSJ

15 sept. 2024, 09:30 UTC

Top știri

Interest Rates Are Too High. The Fed Should Cut by a Half Point. -- WSJ

15 sept. 2024, 07:00 UTC

Top știri

World's Biggest Hedge Fund Sells Apple, Eli Lilly Stock, and Buys Microsoft, Moderna -- Barrons.com

14 sept. 2024, 14:09 UTC

Top știri

Disney, DirecTV Reach Deal, Ending Blackout of ABC, ESPN -- Update 1 -- WSJ

14 sept. 2024, 13:25 UTC

Top știri

Disney, DirecTV Reach Deal, Ending Blackout of ABC, ESPN -- WSJ

14 sept. 2024, 09:30 UTC

Top știri

Why a Fed Rate Cut Won't Solve the Housing Wealth Gap -- WSJ

14 sept. 2024, 09:30 UTC

Top știri

Americans Are Falling Behind on Their Bills. Wall Street Is Alarmed. -- WSJ

14 sept. 2024, 03:00 UTC

Top știri

What Scared Ford's CEO in China -- WSJ

14 sept. 2024, 03:00 UTC

Top știri

What Scared Ford's CEO in China -- WSJ -2-

14 sept. 2024, 00:01 UTC

Top știri

Why 96% of Boeing's Machinists Voted to Go on Strike -- Update

13 sept. 2024, 21:14 UTC

Top știri

Why 96% of Boeing's Machinists Voted to Go on Strike -- WSJ

13 sept. 2024, 21:06 UTC

Top știri

Starliner Astronauts Say NASA Ran Short of Time to Test Boeing Craft -- WSJ

13 sept. 2024, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

13 sept. 2024, 20:47 UTC

Market Talk

Saudi Arabia Credit Outlook Raised to Positive on Economic Investments -- Market Talk

13 sept. 2024, 20:44 UTC

Achiziții, Fuziuni, Preluări

Schlumberger Stock Was Once as Hot as Nvidia. Why It's a Buy. -- Barrons.com

13 sept. 2024, 20:41 UTC

Top știri

Berkshire Hathaway's Stock Is So Rich Even Berkshire Is Buying Less of It -- Update

13 sept. 2024, 20:31 UTC

Câștiguri

These Stocks Moved the Most Today: Adobe, Boeing, Trump Media, Oracle, Uber, RH, Moderna, Etsy, and More -- Barrons.com

13 sept. 2024, 20:13 UTC

Achiziții, Fuziuni, Preluări

BlackRock: Expects to Close Previously Announced Acquisition of Global Infrastructure Partners on Oct 1 >BLK

13 sept. 2024, 20:10 UTC

Achiziții, Fuziuni, Preluări

BlackRock Announces Expected Closing Date For Acquisition Of Global Infrastructure Partners >BLK

13 sept. 2024, 20:02 UTC

Achiziții, Fuziuni, Preluări

CGI Completes Acquisition Of Aeyon, Expands Capabilities For National Security And Civilian Agency Missions >GIB

13 sept. 2024, 20:02 UTC

Achiziții, Fuziuni, Preluări

CGI Completes Acquisition Of Aeyon, Expands Capabilities For National Security And Civilian Agency Missions >GIB

13 sept. 2024, 19:44 UTC

Market Talk

Treasury Yields Fall as Odds of 50bp Fed Cut Rise -- Market Talk

13 sept. 2024, 19:20 UTC

Market Talk

Crude-Oil Futures End Week With Small Gains -- Market Talk

13 sept. 2024, 19:09 UTC

Market Talk

U.S. Natural-Gas Futures Post Weekly Gain -- Market Talk

13 sept. 2024, 18:01 UTC

Market Talk

Gold Analysts Call For New Leg Of Rally -- Market Talk

Comparație

Modificare preț

Repligen Corp Așteptări

Obiectiv de preț

By TipRanks

39.45% sus

Prognoză pe 12 luni

Medie 195.22 USD 39.45%

Maxim 225 USD

Minim 160 USD

În baza a 10 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruRepligen Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

10 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 10 analiști care au acordat evaluări ale acțiunilor Repligen Corp - Dist în ultimele 3 luni.

Scor tehnic

By Trading Central

138.8 / 147.07Suport & Rezistență

Recent bearish events outweigh bullish events.

The bullish and bearish events are balanced.

All events are bearish.

Sentiment

By Acuity

97 / 365 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Repligen Corp

Repligen Corporation is a life sciences company that develops and commercializes bioprocessing technologies and systems that rises flexibility in the process of manufacturing biological drugs. The Company's bioprocessing business consist of four franchises, Filtration; Chromatography; Process Analytics; and Proteins. The Filtration products are used in process development and process scale (clinical and commercial) production. The Chromatography franchise includes products used in downstream purification, development, and manufacturing of biological drugs. The Process Analytics products allow end-users to make in-line absorbance measurements allowing for the determination of protein concentration in filtration, chromatography formulation and fill-finish applications. The Proteins franchise is represented by its Protein A affinity ligands, which are a critical component of Protein A chromatography resins used in downstream purification of virtually all mAb-based drugs on the market.